![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Alum (AlK(SO4)2) is an adjuvant commonly utilized in vaccines, and is a ubiquitous element used extensively in contemporary life. Food, air, water, waste, the earth’s surface, and pharmaceuticals all represent pathways of aluminum (Al) exposure. Crohn's disease (CD) is a chronic relapsing intestinal inflammation in genetically susceptible individuals and is caused by yet unidentified environmental factors. Al is a potential factor for the induction of inflammation in CD, and its immune activities share many characteristics with the immune pathology of CD: many luminal bacterial or dietary compounds can be adsorbed to the metal surface and induce Th1 profile cytokines, shared cytokines/chemokines, co-stimulatory molecules, and intracellular pathways and stress-related molecular expression enhancement, affecting intestinal macrobiota, trans-mural granuloma formation, and colitis induction in an animal CD model. The inflammasome plays a central role in Al mode of action and in CD pathophysiology. It is suggested that Al adjuvant activity can fit between the aberrations of innate and adaptive immune responses occurring in CD. The CD mucosa is confronted with numerous inappropriate bacterial components adsorbed on the Al compound surface, constituting a pro-inflammatory supra-adjuvant. Al fits the diagnostic criteria of the newly described autoimmune/inflammatory syndrome induced by adjuvants. If a cause and effect relationship can be established, the consequences will greatly impact public health and CD prevention and management.
Keywords
References
| 1. | Sartor, RB . Key questions to guide a better understanding of host-commensal microbiota interactions in intestinal inflammation. Mucosal Immunol 2011; 4: 127–132. Google Scholar | Crossref | Medline | ISI |
| 2. | Bamias, G, Nyce, MR, De La Rue, SA, Cominelli, F. New concepts in the pathophysiology of inflammatory bowel disease. Ann Inter Med 2005; 143: 895–904. Google Scholar | Crossref | Medline | ISI |
| 3. | Sartor, RB . Therapeutic manipulation of the enteric microflora in inflammatory bowel disease: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620–1633. Google Scholar | Crossref | Medline | ISI |
| 4. | Lerner, A, Shoenfeld, Y. Serological markers in inflammatory bowel disease: the pros and cons. Eur J Gastroenterol Hepatol 2002; 14: 103–105. Google Scholar | Crossref | Medline | ISI |
| 5. | Mahmud, N, Weir, DG. The urban diet and Crohn's disease: is there a relationship? Eur J Gastroenterol Hepatol 2001; 13: 93–95. Google Scholar | Crossref | Medline | ISI |
| 6. | Xia, TL, Li, N, Nel, AE. Potential health impact of nanoparticles. Ann Rev Pub Health 2009; 30: 137–150. Google Scholar | Crossref | Medline | ISI |
| 7. | Powell, JJ, Faria, N, Thomas-McKay, E, Pele, LC. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 2010; 34: j226–j233. Google Scholar | Crossref | Medline | ISI |
| 8. | Ganrot, PO . Aluminum: possible etiologic agent in Crohn's disease. In: Jarnerot, G (eds). Inflammatory bowel disease New York: Raven Press; 1987. 119–128. Google Scholar |
| 9. | Perl, DP, Fogarty, U, Harpaz, N. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis 2004; 10: 881–883. Google Scholar | Crossref | Medline | ISI |
| 10. | Lerner, A . Extended hypothesis: Aluminum is a potential environmental factor for Crohn's disease induction. Ann N Y Acad Sci 2007; 1107: 329–345. Google Scholar | Crossref | Medline | ISI |
| 11. | Lomer, MC, Thompson, RP, Powell, JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002; 61: 123–130. Google Scholar | Crossref | Medline | ISI |
| 12. | Shepherd, NA, Crocker, PR, Smith, AP. Exogenous pigment in Peyer's patches. Hum Pathol 1987; 18: 50–54. Google Scholar | Crossref | Medline | ISI |
| 13. | Urbanski, SJ, Arsenault, AL, Green, FH. Pigment resembling atmospheric dust in Peyer's patches. Mod Pathol 1989; 2: 222–226. Google Scholar | Medline | ISI |
| 14. | Powell, JJ, Ainley, C, Harvey, RS. Characterization of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 2007; 38: 390–395. Google Scholar | Crossref | ISI |
| 15. | Powell, JJ, Thoree, V, Pele, LC. Dietary microparticles and their impact on tolerance and immune responsiveness of the gastrointestinal tract. Br J Nutr 2007; 98: s59–s63. Google Scholar | Crossref | Medline | ISI |
| 16. | Chess, S, Chess, D, Olander, G. Production of chronic enteritis and other systemic lesions by ingestion of finely divided foreign materials. Surgery 1950; 27: 220–234. Google Scholar | Medline | ISI |
| 17. | Fogarty, U, Perl, D, Good, P. A cluster of equine granulomatous enteritis cases: the link with aluminium. Vet Hum Toxicol 1998; 40: 297–305. Google Scholar | Medline |
| 18. | Lerner, A, Eluri, S, Perl, D. Bacterial-aluminum interactions. The role of aluminum in bacterial-induced colitis in IL-10 deficient mice. Gastroenterology 2006; 130: 362–363. abstract). Google Scholar |
| 19. | Di Sabatino, A, Ciccocioppo, R, Luinetti, O. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum 2003; 46: 1498–1507. Google Scholar | Crossref | Medline | ISI |
| 20. | Lerner, A . New therapeutic strategies for celiac disease. Autoimmun Rev 2010; 9: 144–147. Google Scholar | Crossref | Medline | ISI |
| 21. | Salim, SY, Soderholm, JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17: 362–381. Google Scholar | Crossref | Medline | ISI |
| 22. | Zaki, MH, Lamkanfi, M, Kanneganti, TD. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol 2011; 32: 171–179. Google Scholar | Crossref | Medline | ISI |
| 23. | Aimanianda, V, Haensler, J, Lacroix-desmazes, S, Kaveri, SV, Bayry, J. Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharmacol Sci 2009; 30: 287–295. Google Scholar | Crossref | Medline | ISI |
| 24. | Mankertz, J, Schulzke, JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 2007; 23: 379–383. Google Scholar | Crossref | Medline | ISI |
| 25. | Gullberg, E, Soderholm, JD. Peyer's patches and M cells as a potential sites of the inflammatory onset in Crohn's disease. Ann N Y Acad Sci 2006; 1072: 218–232. Google Scholar | Crossref | Medline | ISI |
| 26. | Ashwood, P, Thompson, RP, Powell, JJ. Fine particles that adsorb lipopolysacchride via bridging calcium cations may mimic bacterial pathogenicity towards cells. Exp Biol Med 2007; 232: 107–117. Google Scholar | Abstract | ISI |
| 27. | Powell, JJ, Harvey, RS, Ashwood, P, Wolstencroft, R, Gershwin, ME, Thompson, RP. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 2000; 14: 99–105. Google Scholar | Crossref | Medline | ISI |
| 28. | Evans, SM, Ashwood, P, Warley, A, Berisha, F, Thompson, RPH, Powell, JJ. The role of dietary microparticles and calcium in apoptosis and interleukin-1ß release of intestinal macrophages. Gastroenterology 2002; 123: 1543–1553. Google Scholar | Crossref | Medline | ISI |
| 29. | Thoree, V, Skepper, J, Deere, H, Pele, LC, Thompson, RP, Powell, JJ. Phenotype of exogenous microparticle-containing pigment cells of the human Peyer's patch in inflamed and normal ileum. Inflamm Res 2008; 57: 374–378. Google Scholar | Crossref | Medline | ISI |
| 30. | Pele, LC, Powell, JJ. Microparticles: a link between modern life and inflammatory bowel disease? In: Colombel, JF, Gasche, C, Scholmerich, J, Vucelic, B (eds). IBD: translation from basic research to clinical practice Dordrecht: Kluwer Academic Publishers; 2005. 123–137. Google Scholar | Crossref |
| 31. | Powell, JJ, Harvey, RS, Thompson, RP. Microparticles in Crohn's disease–has the dust settled? Gut 1996; 39: 340–341. Google Scholar | Crossref | Medline | ISI |
| 32. | Lomer, MC, Hutchinson, C, Volkert, S. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br J Nutr 2004; 92: 947–955. Google Scholar | Crossref | Medline | ISI |
| 33. | Butler, M, Boyle, JJ, Powell, JJ, Playford, RJ, Ghosh, S. Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res 2007; 56: 353–361. Google Scholar | Crossref | Medline | ISI |
| 34. | Mannhalter, JW, Neychev, HO, Zlabinger, GJ. Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin Exp Immunol 1985; 61: 143–151. Google Scholar | Medline | ISI |
| 35. | Saitoh, T, Fujita, N, Jang, MH. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456: 264–268. Google Scholar | Crossref | Medline | ISI |
| 36. | Lomer, MC, Harvey, RS, Evans, S-M. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol 2001; 13: 101–106. Google Scholar | Crossref | Medline | ISI |
| 37. | Lomer, MC, Grainger, SL. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur J Gastroenterol Hepatol 2005; 17: 377–384. Google Scholar | Crossref | Medline | ISI |
| 38. | Mitsuhashi, M, Targan, SR. Ex vivo stimulation of IgG Fc and T-cell receptor function: an application to inflammatory bowel disease. Inflamm Bowel Dis 2006; 14: 1061–1067. Google Scholar | Crossref | ISI |
| 39. | Vuckovic, S, Florin, TH, Khalil, D. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel disease. Am J Gastroenterology 2001; 96: 2946–2956. Google Scholar | Crossref | Medline | ISI |
| 40. | Philpott, JR, Miner, PB. Antisense inhibition of ICAM-1 expression as therapy provides insight into basic inflammatory pathways through early experiences in IBD. Expert Opin Biol Ther 2008; 8: 1627–1632. Google Scholar | Crossref | Medline | ISI |
| 41. | Papadakis, KA . Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep 2004; 4: 83–89. Google Scholar | Crossref | Medline | ISI |
| 42. | Stallmach, A, Giese, T, Schmidt, C. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorectal Dis 2004; 19: 308–315. Google Scholar | Crossref | Medline |
| 43. | Kaser, A, Blumberg, RS. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology 2011; 140: 1738–1747. Google Scholar | Crossref | Medline | ISI |
| 44. | Marrack, P, McKee, A, Munks, MW. Towards an understanding of the adjuvant action of aluminum. Nature Rev Immunol 2009; 9: 287–293. Google Scholar | Crossref | Medline | ISI |
| 45. | Dotan, I, Fishman, S, Dgani, Y. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease. Gastroenterology 2006; 131: 366–378. Google Scholar | Crossref | Medline | ISI |
| 46. | Lindblad, EB . Aluminum compounds for use in vaccines. Immun Cell Biol 2004; 82: 497–505. Google Scholar | Crossref | Medline | ISI |
| 47. | Wasan, SK, Baker, SE, Skolnik, PR, Farraye, FA. A practical guide to vaccinating the inflammatory bowel disease. Patient Amer J Gastroenterol 2010; 105: 1231–1238. Google Scholar | Crossref | Medline | ISI |
| 48. | Bamonti F, Fulgenzi A, Novembrino C, Ferrero ME. Metal chelation therapy in rheumatoid arthritis: a case report. Biometals 2011; 24: 1093–1098. Google Scholar |
| 49. | Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Macrophage myofasciitis a vaccine (alum) autoimmune-related disease. Clin Rev Allergy Immun 2011; 41: 163–168. Google Scholar |
| 50. | Flaten, TP . Aluminum as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bull 2001; 15: 187–196. Google Scholar | Crossref | ISI |
| 51. | Exley, C, Mamutse, G, Korchazhkina, O. Elevated urinary excretion of aluminum and iron in multiple sclerosis. Mult Scler 2006; 12: 533–540. Google Scholar | SAGE Journals | ISI |
| 52. | Cai, HR, Cao, M, Meng, FQ, Wei, JY. Pulmonary sarcoid-like granulomatosis induced by aluminum dust: report of a case and literature review. Chin Med J 2007; 120: 1556–1560. Google Scholar | Crossref | Medline | ISI |
| 53. | de Carvalho, JF, Pereira, RM, Shoenfeld, Y. The mosaic of autoimmunity: the role of environmental factors. Front Biosci (Elite edn) 2009; 1: 501–509. Google Scholar | Medline |
| 54. | Molina, V, Shoenfeld, Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005; 38: 235–245. Google Scholar | Crossref | Medline | ISI |
| 55. | Shoenfeld, Y . Infections, vaccines and autoimmunity. Lupus 2009; 18: 1127–1128. Google Scholar | SAGE Journals | ISI |
| 56. | Israeli, E, Agmon-Levin, N, Blank, M, Shoenfeld, Y. Adjuvants and autoimmunity. Lupus 2009; 18: 1217–1225. Google Scholar | SAGE Journals | ISI |
| 57. | Fournie, GJ, Mas, M, Cautain, B. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun 2001; 16: 319–326. Google Scholar |
| 58. | Meroni, PL . Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truth and a new syndrome? J Autoimmun 2011; 36: 1–3. Google Scholar | Crossref | Medline | ISI |
| 59. | Shoenfeld, Y, Agmon-levin, N. ‘ASIA’-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4–8. Google Scholar | Crossref | Medline | ISI |
